62 related articles for article (PubMed ID: 10626684)
21. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
[TBL] [Abstract][Full Text] [Related]
22. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Ebert EC; Geng X; Lin J; Das KM
Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
[TBL] [Abstract][Full Text] [Related]
24. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis.
Ebert EC; Geng X; Bajpai M; Pan Z; Tatar E; Das KM
Am J Gastroenterol; 2009 Dec; 104(12):2996-3003. PubMed ID: 19690525
[TBL] [Abstract][Full Text] [Related]
25. The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
Raiter A; Vilkin A; Gingold R; Levi Z; Halpern M; Niv Y; Hardy B
Int J Biol Markers; 2014 Dec; 29(4):e431-5. PubMed ID: 24803280
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
27. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
[TBL] [Abstract][Full Text] [Related]
28. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama S; Yamasaki K; Kawahara M; Kaminishi M
Clin Cancer Res; 1999 May; 5(5):1125-30. PubMed ID: 10353747
[TBL] [Abstract][Full Text] [Related]
29. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
[TBL] [Abstract][Full Text] [Related]
30. Normalization of serum p53 antibody levels in patients after curative resection for colorectal cancer.
Kawahara H; Watanabe K; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 May; 33(5):2221-5. PubMed ID: 23645779
[TBL] [Abstract][Full Text] [Related]
31. Anti-ovarian antibodies in sera of patients with ovarian tumors.
Szubert S; Michalak S; Szpurek D; Moszynski R; Krygowska-Zielinska J; Sajdak S
Immunol Lett; 2012 Dec; 148(2):133-7. PubMed ID: 23026238
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
[TBL] [Abstract][Full Text] [Related]
33. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
34. Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies.
Bielicki D; Karbowniczek M; Sulzyc-Bielicka V; Kładny J; Boer C; Marlicz K; Domagała W
Pol J Pathol; 1999; 50(2):77-81. PubMed ID: 10481530
[TBL] [Abstract][Full Text] [Related]
35. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
36. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma.
Sun Y; Zhang R; Wang M; Zhang Y; Qi J; Li J
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2043-7. PubMed ID: 22832207
[TBL] [Abstract][Full Text] [Related]
37. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
Conry RM; Allen KO; Lee S; Moore SE; Shaw DR; LoBuglio AF
Clin Cancer Res; 2000 Jan; 6(1):34-41. PubMed ID: 10656429
[TBL] [Abstract][Full Text] [Related]
38. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
39. [Immunologic tests: Anti-tropomyosin antibody].
Fujita A; Hidaka Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():532-5. PubMed ID: 16111323
[No Abstract] [Full Text] [Related]
40. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]